Meet Robert Dennehy, NGT’s Crystallization and Solid-State Subject Matter Expert
Our people are at the core of our business. Twice monthly we are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today we highlight Robert Dennehy, NGT’s Crystallization and Solid-State Expert.
NGT’s Robert Dennehy has 28 years of experience working in the pharmaceutical industry as a process chemist, now focusing on strategy through leadership, education, and development of partnerships across the US and UK.
Robert’s core expertise is in API solid state and crystallization but spans chemistry and formulation. He played a critical role in the development of more than 10 late phase and marketed NCEs including QbD and risk assessment. During his time at GSK, Dr. Dennehy led the development of both crystallization and solid-state small molecule assets, numbering over 30.
For more information on Robert’s expertise, or to get in touch regarding your drug development project, contact us at [email protected]